Immunologic and Genetic Factors in Type 1 Diabetes
Open Access
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (46) , 43545-43548
- https://doi.org/10.1074/jbc.r200012200
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Targeted Disruption of the Protein Tyrosine Phosphatase-Like Molecule IA-2 Results in Alterations in Glucose Tolerance Tests and Insulin SecretionDiabetes, 2002
- Diabetes mellitus and genetically programmed defects in β-cell functionNature, 2001
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Autoimmune type 1 diabetes: resolved and unresolved issuesJournal of Clinical Investigation, 2001
- Type 1 diabetes: new perspectives on disease pathogenesis and treatmentThe Lancet, 2001
- The HLA SystemNew England Journal of Medicine, 2000
- Susceptibility to type I diabetes: HLA-DQ and DR revisitedImmunology Today, 1996
- IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.Proceedings of the National Academy of Sciences, 1996
- Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.Proceedings of the National Academy of Sciences, 1996
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990